LCI699
| CAS No. | 928134-65-0 | Cat. No. | BCP16339 |
| Name | LCI699 | ||
| Synonyms | LCI-699;LCI 699;Osilodrostat; | ||
| Formula | C13H10FN3 | M. Wt | 227.24 |
| Description | Osilodrostat, also known as LCI699, is a potent inhibitor of 11β-hydroxylase, the enzyme which catalyzes the final step of cortisol synthesis. LCI699 may thus be a potential new treatment for all forms of Cushing's syndrome. Current evidence indicates that the novel aldosterone inhibitor LCI699 is an effective and well-tolerated antihypertensive agent that lowers plasma aldosterone concentration and produces a mild ACTH-stimulated cortisol response suppressive effect. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | MLR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.